| AT | anthrax toxin |
| Bcl-XL | B-cell lymphoma-extra large |
| CMG2 or ANTXR2 | capillary morphogenesis gene 2 |
| CdtB | cytolethal distending toxin B |
| DTA | diphtheria toxin A chain |
| EF | edema factor |
| ET | edema toxin |
| LF | lethal factor |
| LFn | LF N-terminal domain |
| LT | lethal toxin |
| MMPs | matrix-metalloproteases |
| MAPKKs | mitogen-activated protein kinase kinases |
| mPA | mutant PA |
| mPA-EGF | mPA genetically fused to human epidermal growth factor |
| mPA-ZHER2 | mPA genetically fused to the affibody ZHER2 |
| PA | protective antigen |
| PA-DK | PA with D512K mutation |
| PA-GN | PA with mutation complementing PA-D512K mutation |
| PE | Pseudomonas exotoxin A |
| PEIII | Pseudomonas exotoxin A catalytic domain |
| PE38 | PE domains II and III |
| Raf-1 | rapidly accelerated fibrosarcoma |
| TEM8 or ANTXR1 | tumor endothelial marker 8 |
| uPa | urokinase plasminogen activator |